CompletedNCT05045495
Adult Pilot Study for Reference Ranges and Optimal Cut-offs for the Sucrose Challenge Test and Sucrose Breath Test
Studying Congenital sucrase-isomaltase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- QOL Medical, LLC
- Principal Investigator
- Weng Tao, M.D., Ph. DQOL Medical
- Intervention
- Sucrose Hydrogen Methane Breath Test(diagnostic_test)
- Enrollment
- 211 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2022
Study locations (1)
- Science 37-Recruiting Nationally, Culver City, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05045495 on ClinicalTrials.govOther trials for Congenital sucrase-isomaltase deficiency
Additional recruiting or active studies for the same condition.
See all trials for Congenital sucrase-isomaltase deficiency →